Bronchiectasis and COVID-19 infection:a two-way street  

作　　者：Grace Oscullo Jose DanieGómez-Olivas Thais Beauperthuy AminaBekki Alberto Garcia-Ortega Maria Gabriella Matera Mario Cazzola Miguel Angel Martinez-Garcia 

机构地区：[1]Department of Pneumology,Hospital Universitario y Politécnico la Fe de Valencia,Valencia 46012,Spain [2]Department of Experimental Medicine,University of Campania“Luigi Vanvitelli”,Naples 80121,Italy [3]Department of Experimental Medicine,University of Rome Tor Vergata,Rome 00185,Italy [4]CIBERES de enfermedades respiratorias,Instituto de Salud Carlos III,Madrid 41263,Spain

出　　处：《Chinese Medical Journal》2022年第20期2398-2404,共7页中华医学杂志（英文版）

摘　　要：Bronchiectasis(BE)has been linked to past viral infections such as influenza,measles,or adenovirus.Two years ago,a new pandemic viral infection severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)broke out and it still persists today,and a significant proportion of surviving patients have radiological and clinical sequelae,including BE.Our aim was to thoroughly review the information available in the literature on the bidirectional relationship between SARS-CoV-2 infection and the development of BE,as well as the impact of this infection on patients already suffering from BE.Available information indicates that only a small percentage of patients in the acute phase of coronavirus disease 2019(COVID-19)pneumonia develop BE,although the latter is recognized as one of the radiological sequelae of COVID-19 pneumonia,especially when it is caused by traction.The severity of the initial pneumonia is the main risk factor for the development of future BE,but during the COVID-19 pandemic,exacerbations in BE patients were reduced by approximately 50%.Finally,the impact of BE on the prognosis of patients with COVID-19 pneumonia is not yet known.

关 键 词：BRONCHIECTASIS CORONAVIRUS COVID-19 SARS-CoV-2 

分 类 号：R563.1[医药卫生—呼吸系统]